Enduring Activity: Clinical Updates in Alzheimer’s Disease Symposium - Understanding Biomarkers in Alzheimer’s Disease
Target Audience
This activity is targeted toward physicians, advanced practice providers, nurses and other clinicians.
Statement of Need
In the care of patients, memory is not always addressed as an integral part of the patient exam unless there is a complaint of memory loss. Therefore, identification of patients with memory loss often is identified later in the course of dementia. This program will equip primary care providers with knowledge of basic cognitive screening tests and brain imaging to identify patients who would benefit from specialized treatment. This would result in earlier diagnosis and treatment of neurodegenerative diseases.
Objectives
At the conclusion of this offering, the participant will be able to:
• Determine when biomarkers are used in the diagnosis of Alzheimer’s Disease
• List the different types of biomarkers available for diagnosing Alzheimer’s Disease
• Recognize limitations in the use of these biomarkers
Faculty
Rachel Hart, D.O.
Geriatric Medicine Physician
Memory and Cognitive Disorders Specialist
Norton Neuroscience Institute Memory Center
Faculty Disclosure
The speaker, Rachel Hart, D.O., has no relevant financial relationships with ineligible companies to disclose.
Planner & Moderator Disclosure
Planners and moderator for this course have no relevant financial relationships with ineligible companies to disclose.
Commercial Support
This activity has not received commercial support.
Physicians
Accreditation
Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.
Designation
Norton Healthcare designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Nursing Credits
For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org.
Date of Original Release | June 20, 2024
Course Termination Date | June 2026
Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org
Evaluation
www.surveymonk...
Resources
Angioni D, Delrieu J, Hansson O, Fillit H, Aisen P, Cummings J, Sims JR, Braunstein JB, Sabbagh M, Bittner T, Pontecorvo M, Bozeat S, Dage JL, Largent E, Mattke S, Correa O, Gutierrez Robledo LM, Baldivieso V, Willis DR, Atri A, Bateman RJ, Ousset PJ, Vellas B, Weiner M. Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force. J Prev Alzheimers Dis. 2022;9(4):569-579. doi: 10.14283/jpad.2022.85. PMID: 36281661; PMCID: PMC9683846. www.ncbi.nlm.n...
Gunes S, Aizawa Y, Sugashi T, Sugimoto M, Rodrigues PP. Biomarkers for Alzheimer's Disease in the Current State: A Narrative Review. Int J Mol Sci. 2022 Apr 29;23(9):4962. doi: 10.3390/ijms23094962. PMID: 35563350; PMCID: PMC9102515. pubmed.ncbi.nl...
Join our online community and stay connected with Norton Healthcare for the latest news, events, and resources to support your well-being. ⬇️
📘 Facebook: / nortonhealthcare
📣 X (Twitter): / norton_health
📸 Instagram: / nortonhealth
🔗 LinkedIn: / norton-healthcare
🎥 TikTok: / nortonhealthcare